Award

Delivery Order #75N98027F00001

Synthesis of GMP Ketanserin Task Order under Long-Term Bulk Drug IDIQ Contract

Buyer

National Institutes of Health

Award Amount

$687,612.00

Ceiling

$687,612.00

Awarded

October 20, 2026

Period of Performance

Oct 20, 2026 – Jan 30, 2028

Identifier

75N98027F00001

NAICS

541715

This award represents a delivery order under a definitive indefinite-delivery indefinite-quantity (IDIQ) contract focused on the cGMP synthesis of bulk drug substances. The recipient, Benuvia Operations, LLC, specializes in the production of pharmaceutical-grade active ingredients, and this task order specifically involves the synthesis of GMP-grade ketanserin, a pharmaceutical compound. The contract is a vital component of the agency's long-term acquisition strategy to secure high-quality pharmaceutical substances, ensuring compliance with regulatory standards for medical applications. The scope includes the synthesis, quality control, and timely delivery of ketanserin according to cGMP guidelines. This delivery order was issued under a competitive and structured IDIQ contract awarded previously to Benuvia, allowing streamlined procurements within the defined ordering period. The duration of this task order spans over a year, with potential extension aligning with the parent contract's multi-year timeframe. The contract enhances supply chain reliability for critical pharmaceutical materials and underscores the agency's commitment to supporting pharmaceutical manufacturing capabilities in the public sector.

Description

TASK ORDER 2, SYNTHESIS OF GMP KETANSERIN

View original record